Archive for 2005

Nearly 50 new biotech medicines in pipeline

There could be as many as 50 new biotechnology medicines approved for commercial use in the coming months, thanks to advances in biotechnology research and development, according to a study released March 7.


Click here for reuse options!
Copyright 2005 Biotechblog

Biotech Buyout Binge Continues

For the second week in a row, buyout rumors and merger speculation sent a number of biotech and specialty pharmaceutical shares higher.


Click here for reuse options!
Copyright 2005 Biotechblog

Ad Changes Ahead for Controversial Drugs

Ad executives and drug company officials say changes in advertising strategies are almost a certainty in the wake of the Vioxx and Celebrex news and new studies showing a consumer backlash.


Click here for reuse options!
Copyright 2005 Biotechblog

U.N. Calls for Clone Ban

The United Nations has called on countries to ban all forms of human cloning “incompatable with human dignity.” The American religious right claims victory, but others say the declaration is the result of political maneuvering influenced by pressure from the United States.


Click here for reuse options!
Copyright 2005 Biotechblog

Will California's Stem Cell Initiative Reap Royalties?

When the backers of California’s stem cell initiative were seeking voter support last year, they not only promised cures for dread diseases, but also licensing revenue for the state. A statement posted on the initiative proponents’ CuresforCalifornia.com Web site says that ‘California will benefit for decades from patents and royalties that result from the research.’ […]


Click here for reuse options!
Copyright 2005 Biotechblog

Will California’s Stem Cell Initiative Reap Royalties?

When the backers of California’s stem cell initiative were seeking voter support last year, they not only promised cures for dread diseases, but also licensing revenue for the state. A statement posted on the initiative proponents’ CuresforCalifornia.com Web site says that ‘California will benefit for decades from patents and royalties that result from the research.’ […]


Click here for reuse options!
Copyright 2005 Biotechblog

FDA Plans New Board To Monitor Drug Safety

The Food and Drug Administration will create an independent board to more aggressively monitor the safety of drugs on the market as part of an effort to restore public confidence in the nation’s prescription drug supply, Health and Human Services Secretary Mike Leavitt announced yesterday.


Click here for reuse options!
Copyright 2005 Biotechblog

More Roadblocks Ahead For Pharma in 2005?

The pharmaceutical industry was traumatized in 2004 when Merck had to withdraw its $2.5 billion COX-2 inhibitor Vioxx from the market due to potentially lethal side effects. Pharmaceutical companies are already struggling to deal with increasing generic competition and stringent approval standards in an effective manner. Will the aftereffects of a disastrous 2004 hamper industry […]


Click here for reuse options!
Copyright 2005 Biotechblog

Genetically Modified IP Launched

Genetically Modified IP Launched A paper appearing in this week’s edition of Nature is antiseptically entitled: ‘Gene transfer to plants by diverse species of bacteria.’ But the information that lies within may herald a revolution in biology.


Click here for reuse options!
Copyright 2005 Biotechblog

%d bloggers like this: